National epidemiology of dermatofibrosarcoma protuberans, England 2013–2022

The incidence data for England from 2013 to 2022 indicates that there were 171 cases every year on average, which gives a crude incidence rate of 0.31 per 100 000 person-years and a nonsignificant annual increase of 1.42%, before the COVID-19 pandemic, 2013–2019. Dermatofibrosarcoma protuberans (DFSP) has a high 5-year net survival rate of 99.2% and an overall survival rate of 96.5%, which indicates a generally favourable DFSP prognosis once resected.

Authors

Institutions

Publication Details

Journal
British Journal of Dermatology
Published
2025-10-13
DOI
https://doi.org/10.1093/bjd/ljaf401
Citations
1
Primary Topic
Sarcoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
1.52
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

National epidemiology of dermatofibrosarcoma protuberans, England 2013–2022

William Perkins, Charles M.G. Archer, Birgitta van Bodegraven, Zoe Claire Venables et al.
1 citations
British Journal of Dermatology
Sarcoma Diagnosis and Treatment
1.52
article

National epidemiology of dermatofibrosarcoma protuberans, England 2013–2022

William Perkins, Charles M.G. Archer, Birgitta van Bodegraven, Zoe Claire Venables, Veronica Melchionda
article en
1 citations

Abstract

The incidence data for England from 2013 to 2022 indicates that there were 171 cases every year on average, which gives a crude incidence rate of 0.31 per 100 000 person-years and a nonsignificant annual increase of 1.42%, before the COVID-19 pandemic, 2013–2019. Dermatofibrosarcoma protuberans (DFSP) has a high 5-year net survival rate of 99.2% and an overall survival rate of 96.5%, which indicates a generally favourable DFSP prognosis once resected.

British Journal of DermatologyVol. 194(2)
University of East Anglia (GB), Norfolk and Norwich University Hospital (GB), Churchill Hospital (GB), British Association of Dermatologists (GB), NHS Digital (GB), Churchill Centre (US), NHS England
Openalex Percentile: Top 14%
Sarcoma Diagnosis and Treatment
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.